Link Pharma Chem Board of Directors

Get the latest insights into the leadership at Link Pharma Chem. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Satish Thakur Chairman & Wholetime Director
Mr. Rishikesh Thakur Managing Director
Mr. Rohit J Shah Independent Director
Mr. Rangoli S Gada Independent Director
Mrs. Rachna Ghai Independent Director

Link Pharma Chem Share price

LINKPH

29.85

0.25 (0.84%)
Last updated on 20 Feb, 2026 | 15:13 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

32.00

Today's Low

28.01

52 Week Low

26.40

52 Week High

42.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Link Pharma Chem FAQs

The board at Link Pharma Chem consists of experienced professionals, including Mr. Satish Thakur , Mr. Rishikesh Thakur , and others, overseeing the company’s strategic and corporate governance.

Directors at Link Pharma Chem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Satish Thakur is the current chairman at Link Pharma Chem.

Executive directors at Link Pharma Chem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Link Pharma Chem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Link Pharma Chem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost